Antibiotic resistance in Latin America: A cause for alarm

M. Teresa Valenzuela; Ciro de Quadros

doi:10.1016/j.vaccine.2009.06.005

Antibiotic resistance in Latin America: A cause for alarm

M. Teresa Valenzuela^*
, Ciro de Quadros

^*Corresponding author for this work

Facultad de Medicina

Research output: Contribution to journal › Article › peer-review

24 Scopus citations

Abstract

The burden of pneumococcal disease in Latin America is most pronounced in children aged <6 years. The increasing rate of resistance of Streptococcus pneumoniae to penicillin and other antibiotics has generated concern among health authorities, since infection by antibiotic-resistant serotypes may be associated with increased mortality. Increased resistance is due to a number of factors including high antibiotic usage in this region. Vaccination with pneumococcal conjugate vaccines offers an effective approach to counter resistant disease due to covered serotypes. Existing surveillance systems must be continued to recognise changes in patterns of resistance and the serotypes that cause pneumococcal disease.

Original language	English
Pages (from-to)	C25-C28
Journal	Vaccine
Volume	27
Issue number	SUPPL. 3
DOIs	https://doi.org/10.1016/j.vaccine.2009.06.005
State	Published - 21 Aug 2009

Bibliographical note

Funding Information:
The authors thank Excerpta Medica (Bridgewater, NJ) for professional writing assistance, which was funded by Wyeth Pharmaceuticals, Collegeville, PA.

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Keywords

Antibiotic resistance
PCV7
Streptococcus pneumoniae

Access to Document

10.1016/j.vaccine.2009.06.005

Cite this

@article{ad9a8e27f8f8498782f8919ef4fca438,

title = "Antibiotic resistance in Latin America: A cause for alarm",

abstract = "The burden of pneumococcal disease in Latin America is most pronounced in children aged <6 years. The increasing rate of resistance of Streptococcus pneumoniae to penicillin and other antibiotics has generated concern among health authorities, since infection by antibiotic-resistant serotypes may be associated with increased mortality. Increased resistance is due to a number of factors including high antibiotic usage in this region. Vaccination with pneumococcal conjugate vaccines offers an effective approach to counter resistant disease due to covered serotypes. Existing surveillance systems must be continued to recognise changes in patterns of resistance and the serotypes that cause pneumococcal disease.",

keywords = "Antibiotic resistance, PCV7, Streptococcus pneumoniae, Antibiotic resistance, PCV7, Streptococcus pneumoniae",

author = "Valenzuela, \{M. Teresa\} and \{de Quadros\}, Ciro",

note = "Funding Information: The authors thank Excerpta Medica (Bridgewater, NJ) for professional writing assistance, which was funded by Wyeth Pharmaceuticals, Collegeville, PA. ",

year = "2009",

month = aug,

day = "21",

doi = "10.1016/j.vaccine.2009.06.005",

language = "English",

volume = "27",

pages = "C25--C28",

journal = "Vaccine",

issn = "0264-410X",

publisher = "Elsevier Ltd.",

number = "SUPPL. 3",

}

TY - JOUR

T1 - Antibiotic resistance in Latin America

T2 - A cause for alarm

AU - Valenzuela, M. Teresa

AU - de Quadros, Ciro

N1 - Funding Information: The authors thank Excerpta Medica (Bridgewater, NJ) for professional writing assistance, which was funded by Wyeth Pharmaceuticals, Collegeville, PA.

PY - 2009/8/21

Y1 - 2009/8/21

N2 - The burden of pneumococcal disease in Latin America is most pronounced in children aged <6 years. The increasing rate of resistance of Streptococcus pneumoniae to penicillin and other antibiotics has generated concern among health authorities, since infection by antibiotic-resistant serotypes may be associated with increased mortality. Increased resistance is due to a number of factors including high antibiotic usage in this region. Vaccination with pneumococcal conjugate vaccines offers an effective approach to counter resistant disease due to covered serotypes. Existing surveillance systems must be continued to recognise changes in patterns of resistance and the serotypes that cause pneumococcal disease.

AB - The burden of pneumococcal disease in Latin America is most pronounced in children aged <6 years. The increasing rate of resistance of Streptococcus pneumoniae to penicillin and other antibiotics has generated concern among health authorities, since infection by antibiotic-resistant serotypes may be associated with increased mortality. Increased resistance is due to a number of factors including high antibiotic usage in this region. Vaccination with pneumococcal conjugate vaccines offers an effective approach to counter resistant disease due to covered serotypes. Existing surveillance systems must be continued to recognise changes in patterns of resistance and the serotypes that cause pneumococcal disease.

KW - Antibiotic resistance

KW - PCV7

KW - Streptococcus pneumoniae

KW - Antibiotic resistance

KW - PCV7

KW - Streptococcus pneumoniae

UR - https://www.scopus.com/pages/publications/68449099296

U2 - 10.1016/j.vaccine.2009.06.005

DO - 10.1016/j.vaccine.2009.06.005

M3 - Article

C2 - 19540634

AN - SCOPUS:68449099296

SN - 0264-410X

VL - 27

SP - C25-C28

JO - Vaccine

JF - Vaccine

IS - SUPPL. 3

ER -

Antibiotic resistance in Latin America: A cause for alarm

Abstract

Bibliographical note

UN SDGs

Keywords

Access to Document

Other files and links

Fingerprint

Cite this